Solventum (NYSE:SOLV) Updates FY 2025 Earnings Guidance

Solventum (NYSE:SOLV - Get Free Report) issued an update on its FY 2025 earnings guidance on Thursday morning. The company provided earnings per share (EPS) guidance of 5.450-5.650 for the period, compared to the consensus estimate of 5.490. The company issued revenue guidance of -.

Solventum Price Performance

SOLV stock traded up $0.32 during trading on Monday, reaching $80.07. The company's stock had a trading volume of 1,079,511 shares, compared to its average volume of 1,450,193. The company has a quick ratio of 0.83, a current ratio of 1.15 and a debt-to-equity ratio of 2.45. The company's fifty day moving average is $72.78 and its 200-day moving average is $70.20. The company has a market capitalization of $13.83 billion and a P/E ratio of 29.12. Solventum has a 1 year low of $47.16 and a 1 year high of $85.92.

Analysts Set New Price Targets

Several analysts recently issued reports on the company. Morgan Stanley increased their target price on Solventum from $60.00 to $73.00 and gave the stock an "equal weight" rating in a research report on Monday, November 11th. Wells Fargo & Company increased their price objective on shares of Solventum from $73.00 to $75.00 and gave the company an "equal weight" rating in a report on Friday. Bank of America boosted their target price on shares of Solventum from $80.00 to $85.00 and gave the stock a "neutral" rating in a report on Wednesday, February 26th. The Goldman Sachs Group raised their target price on shares of Solventum from $63.00 to $71.00 and gave the company a "sell" rating in a research note on Monday. Finally, Piper Sandler lifted their price target on shares of Solventum from $75.00 to $84.00 and gave the company a "neutral" rating in a report on Friday. One research analyst has rated the stock with a sell rating, nine have issued a hold rating and one has assigned a buy rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of "Hold" and a consensus target price of $78.86.

Solventum Company Profile

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.